|
1
|
International Agency for Research on
Cancer, . WHO. Asbestos (chrysotile, amosite, crocidolite,
tremolite, actinolite, and anthophyllite). IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans Volume 100C. A Review of
Human Carcinogens; Part C: Arsenic. Metals. (Fibres, and Dusts,
Lyon, France). 219–309. 2012.
|
|
2
|
Pavlisko EN and Sporn TA: Mesothelioma.
Pathology of asbestos-associated diseases. 3rd. Springer; Berlin:
pp. 81–140. 2014, View Article : Google Scholar
|
|
3
|
Rusch VW, Giroux D, Kennedy C, Ruffini E,
Cangir AK, Rice D, Pass H, Asamura H, Waller D, Edwards J, et al:
Initial analysis of the international association for the study of
lung cancer mesothelioma database. J Thorac Oncol. 7:1631–1639.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Donaldson K, Murphy FA, Duffin R and
Poland CA: Asbestos, carbon nanotubes and the pleural mesothelium:
A review of the hypothesis regarding the role of long fibre
retention in the parietal pleura, inflammation and mesothelioma.
Part Fibre Toxicol. 7:52010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagai H and Toyokuni S: Biopersistent
fiber-induced inflammation and carcinogenesis: Lessons learned from
asbestos toward safety of fibrous nanomaterials. Arch Biochem
Biophys. 502:1–7. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chew SH and Toyokuni S: Malignant
mesothelioma as an oxidative stress-induced cancer: An update. Free
Radic Biol Med. 86:166–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagai H and Toyokuni S: Differences and
similarities between carbon nanotubes and asbestos fibers during
mesothelial carcinogenesis: Shedding light on fiber entry
mechanism. Cancer Sci. 103:1378–1390. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Toyokuni S: Iron addiction with
ferroptosis-resistance in asbestos-induced mesothelial
carcinogenesis: Toward the era of mesothelioma prevention. Free
Radic Biol Med. 133:206–215. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Toyokuni S: Role of iron in
carcinogenesis: Cancer as a ferrotoxic disease. Cancer Sci.
100:9–16. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohara Y, Chew SH, Shibata T, Okazaki Y,
Yamashita K and Toyokuni S: Phlebotomy as a preventive measure for
crocidolite-induced mesothelioma in male rats. Cancer Sci.
109:330–339. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang L, Chew SH, Nakamura K, Ohara Y,
Akatsuka S and Toyokuni S: Dual preventive benefits of iron
elimination by desferal in asbestos-induced mesothelial
carcinogenesis. Cancer Sci. 107:908–915. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chew SH, Okazaki Y, Akatsuka S, Wang S,
Jiang L, Ohara Y, Ito F, Saya H, Sekido Y and Toyokuni S:
Rheostatic CD44 isoform expression and its association with
oxidative stress in human malignant mesothelioma. Free Radic Biol
Med. 106:91–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang L, Yamashita Y, Chew SH, Akatsuka S,
Ukai S, Wang S, Nagai H, Okazaki Y, Takahashi T and Toyokuni S:
Connective tissue growth factor and β-catenin constitute an
autocrine loop for activation in rat sarcomatoid mesothelioma. J
Pathol. 233:402–414. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang S, Jiang L, Han Y, Chew SH, Ohara Y,
Akatsuka S, Weng L, Kawaguchi K, Fukui T, Sekido Y, et al:
Urokinase-type plasminogen activator receptor promotes
proliferation and invasion with reduced cisplatin sensitivity in
malignant mesothelioma. Oncotarget. 7:69565–69578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ohara Y, Chew SH, Misawa N, Wang S, Somiya
D, Nakamura K, Kajiyama H, Kikkawa F, Tsuyuki Y, Jiang L, et al:
Connective tissue growth factor-specific monoclonal antibody
inhibits growth of malignant mesothelioma in an orthotopic mouse
model. Oncotarget. 9:18494–18509. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Orimo A and Weinberg RA: Stromal
fibroblasts in cancer: A novel tumor-promoting cell type. Cell
Cycle. 5:1597–1601. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
LeBleu VS and Kalluri R: A peek into
cancer-associated fibroblasts: Origins, functions and translational
impact. Dis Model Mech. 11:dmm0294472018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Öhlund D, Elyada E and Tuveson D:
Fibroblast heterogeneity in the cancer wound. J Exp Med.
211:1503–1523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rhim AD, Oberstein PE, Thomas DH, Mirek
ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP,
Tattersall IW, et al: Stromal elements act to restrain, rather than
support, pancreatic ductal adenocarcinoma. Cancer Cell. 25:735–747.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sherman MH, Yu RT, Engle DD, Ding N,
Atkins AR, Tiriac H, Collisson EA, Connor F, Van Dyke T, Kozlov S,
et al: Vitamin D receptor-mediated stromal reprogramming suppresses
pancreatitis and enhances pancreatic cancer therapy. Cell.
159:80–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Öhlund D, Handly-Santana A, Biffi G,
Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V, Oni TE, Hearn SA,
Lee EJ, et al: Distinct populations of inflammatory fibroblasts and
myofibroblasts in pancreatic cancer. J Exp Med. 214:579–596. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Raghu G, Scholand MB, de Andrade J,
Lancaster L, Mageto Y, Goldin J, Brown KK, Flaherty KR, Wencel M,
Wanger J, et al: FG-3019 anti-connective tissue growth factor
monoclonal antibody: Results of an open-label clinical trial in
idiopathic pulmonary fibrosis. Eur Respir J. 47:1481–1491. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Richeldi L, Fernández Pérez ER, Costabel
U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand
MB, Goldin J, et al: Pamrevlumab, an anti-connective tissue growth
factor therapy, for idiopathic pulmonary fibrosis (PRAISE): A phase
2, randomised, double-blind, placebo-controlled trial. Lancet
Respir Med. 8:25–33. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Picozzi VJ, Pipas JM, Koong AC, Giaccia
AJ, Bahary N, Krishnamurthi SS, Lopez CD, O'Dwyer P, Modelska K,
Carney M, et al: FG-3019, a human monoclonal antibody to connective
tissue growth factor, combined with chemotherapy in patients with
locally advanced or metastatic pancreatic ductal adenocarcinoma. J
Cancer Clin Trials. 2:12017.
|
|
27
|
Maeda K, Enomoto A, Hara A, Asai N,
Kobayashi T, Horinouchi A, Maruyama S, Ishikawa Y, Nishiyama T,
Kiyoi H, et al: Identification of Meflin as a potential marker for
mesenchymal stromal cells. Sci Rep. 6:222882016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hara A, Kobayashi H, Asai N, Saito S,
Higuchi T, Kato K, Okumura T, Bando YK, Takefuji M, Mizutani Y, et
al: Roles of the mesenchymal stromal/stem cell marker Meflin in
cardiac tissue repair and the development of diastolic dysfunction.
Circ Res. 125:414–430. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mizutani Y, Kobayashi H, Iida T, Asai N,
Masamune A, Hara A, Esaki N, Ushida K, Mii S, Shiraki Y, et al:
Meflin-positive cancer-associated fibroblasts inhibit pancreatic
carcinogenesis. Cancer Res. 79:5367–5381. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumors (UICC), 7th edn. New
York, NY. Wiley–Liss. 2009.
|
|
31
|
Chew SH, Okazaki Y, Nagai H, Misawa N,
Akatsuka S, Yamashita K, Jiang L, Yamashita Y, Noguchi M, Hosoda K,
et al: Cancer-promoting role of adipocytes in asbestos-induced
mesothelial carcinogenesis through dysregulated adipocytokine
production. Carcinogenesis. 35:164–172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kato T, Noma K, Ohara T, Kashima H,
Katsura Y, Sato H, Komoto S, Katsube R, Ninomiya T, Tazawa H, et
al: Cancer-associated fibroblasts affect intratumoral
CD8+ and FoxP3+ T cells via IL6 in the tumor
microenvironment. Clin Cancer Res. 24:4820–4833. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ruifrok AC and Johnston DA: Quantification
of histochemical staining by color deconvolution. Anal Quant Cytol
Histol. 23:291–299. 2001.PubMed/NCBI
|
|
34
|
Boyle TA, Masago K, Ellison KE, Yatabe Y
and Hirsch FR: ROS1 immunohistochemistry among major genotypes of
non-small-cell lung cancer. Clin Lung Cancer. 16:106–111. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Detre S, Saclani Jotti G and Dowsett M: A
‘quickscore’ method for immunohistochemical semiquantitation:
Validation for oestrogen receptor in breast carcinomas. J Clin
Pathol. 48:876–878. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Husain AN, Colby TV, Ordóñez NG, Allen TC,
Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S,
et al: Guidelines for pathologic diagnosis of malignant
mesothelioma 2017 update of the consensus statement from the
international mesothelioma interest group. Arch Pathol Lab Med.
142:89–108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Attanoos RL, Dojcinov SD, Webb R and Gibbs
AR: Anti-mesothelial markers in sarcomatoid mesothelioma and other
spindle cell neoplasms. Histopathology. 37:224–231. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chirieac LR, Pinkus GS, Pinkus JL,
Godleski J, Sugarbaker DJ and Corson JM: The immunohistochemical
characterization of sarcomatoid malignant mesothelioma of the
pleura. Am J Cancer Res. 1:14–24. 2011.PubMed/NCBI
|
|
39
|
Churg A, Cagle P, Colby TV, Corson JM,
Gibbs AR, Hammar S, Ordonez N, Roggli VL, Tazelaar HD, Travis WD,
et al: The fake fat phenomenon in organizing pleuritis: A source of
confusion with desmoplastic malignant mesotheliomas. Am J Surg
Pathol. 35:1823–1829. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fujii M, Toyoda T, Nakanishi H, Yatabe Y,
Sato A, Matsudaira Y, Ito H, Murakami H, Kondo Y, Kondo E, et al:
TGF-β synergizes with defects in the Hippo pathway to stimulate
human malignant mesothelioma growth. J Exp Med. 209:479–494. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dornhöfer N, Spong S, Bennewith K, Salim
A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, et
al: Connective tissue growth factor-specific monoclonal antibody
therapy inhibits pancreatic tumor growth and metastasis. Cancer
Res. 66:5816–5827. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Neesse A, Frese KK, Bapiro TE, Nakagawa T,
Sternlicht MD, Seeley TW, Pilarsky C, Jodrell DI, Spong SM and
Tuveson DA: CTGF antagonism with mAb FG-3019 enhances chemotherapy
response without increasing drug delivery in murine ductal pancreas
cancer. Proc Natl Acad Sci USA. 110:12325–12330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Finger EC, Cheng CF, Williams TR, Rankin
EB, Bedogni B, Tachiki L, Spong S, Giaccia AJ and Powell MB: CTGF
is a therapeutic target for metastatic melanoma. Oncogene.
33:1093–1100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sinn M, Denkert C, Striefler JK, Pelzer U,
Stieler JM, Bahra M, Lohneis P, Dörken B, Oettle H, Riess H and
Sinn BV: α-Smooth muscle actin expression and desmoplastic stromal
reaction in pancreatic cancer: Results from the CONKO-001 study. Br
J Cancer. 111:1917–1923. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Underwood TJ, Hayden AL, Derouet M, Garcia
E, Noble F, White MJ, Thirdborough S, Mead A, Clemons N, Mellone M,
et al: Cancer-associated fibroblasts predict poor outcome and
promote periostin-dependent invasion in oesophageal adenocarcinoma.
J Pathol. 235:466–477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Valach J, Fík Z, Strnad H, Chovanec M,
Plzák J, Cada Z, Szabo P, Sáchová J, Hroudová M, Urbanová M, et al:
Smooth muscle actin-expressing stromal fibroblasts in head and neck
squamous cell carcinoma: Increased expression of galectin-1 and
induction of poor prognosis factors. Int J Cancer. 131:2499–2508.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fujita H, Ohuchida K, Mizumoto K, Nakata
K, Yu J, Kayashima T, Cui L, Manabe T, Ohtsuka T and Tanaka M:
Alpha-smooth muscle actin expressing stroma promotes an aggressive
tumor biology in pancreatic ductal adenocarcinoma. Pancreas.
39:1254–1262. 2010. View Article : Google Scholar : PubMed/NCBI
|
